ブレーキング
RUДвое российских военнопленных сбежали из колонии в Харьковской областиGLOBALChidimma Adetshina reiterates South African birth amid deportation proceedingsUKGreat Britain household energy bills set to hit three-year high this winterUSMeta and Apple Slammed Over Ads and Apps Promoting AI Deepfake PornARالناتو يستعد لتهديدات إيرانية واستطلاع رأي جديد في إسرائيلCN烏克蘭戰時選舉面臨重重挑戰TRMilletvekili Melih Meriç'i Bıçaklayan Zanlı Seydi Ahmet Keleş'in İfadesi ÇıktıTRİranlı eski Cumhurbaşkanı Hatemi'den ABD ile imzalanan mutabakata destekARتسليم ضابط سوري سابق، وتوترات إسرائيلية تركية، وعمليات واسعة في الضفة الغربيةRUDenmark deploys military conscripts to Greenland amid US annexation threatsRUДвое российских военнопленных сбежали из колонии в Харьковской областиGLOBALChidimma Adetshina reiterates South African birth amid deportation proceedingsUKGreat Britain household energy bills set to hit three-year high this winterUSMeta and Apple Slammed Over Ads and Apps Promoting AI Deepfake PornARالناتو يستعد لتهديدات إيرانية واستطلاع رأي جديد في إسرائيلCN烏克蘭戰時選舉面臨重重挑戰TRMilletvekili Melih Meriç'i Bıçaklayan Zanlı Seydi Ahmet Keleş'in İfadesi ÇıktıTRİranlı eski Cumhurbaşkanı Hatemi'den ABD ile imzalanan mutabakata destekARتسليم ضابط سوري سابق، وتوترات إسرائيلية تركية، وعمليات واسعة في الضفة الغربيةRUDenmark deploys military conscripts to Greenland amid US annexation threats
Newsgather

breast cancer

安定した29 ストーリー12 ソース最終更新日: 19 hours ago

最新のストーリー

41-year-old mother with metastatic breast cancer overcomes tumor's changing nature with new drugs
開発中
健康·6/3/2026AIの概要

41-year-old mother with metastatic breast cancer overcomes tumor's changing nature with new drugs

A 41-year-old mother, "Xiao Ya," successfully battled metastatic breast cancer whose cells changed type three times, from HER2-positive to triple-negative, and finally to HER2-low-positive. New precision drugs, including ADC medications, have helped her overcome the evolving tumor. However, Taiwan's National Health Insurance does not yet cover these treatments for advanced and metastatic HER2-low-positive patients, raising concerns about unequal access to care.

自由时报
2 min read